About OPTIMIZERx
OPTIMIZERx (NASDAQ:OPRX) connects patients, physicians, and pharmaceutical manufacturers through a suite of technology solutions and digital health services. The company's main objective is to improve medication adherence and patient access to care, optimizing health outcomes and reducing costs. Their offerings include digital prescription savings solutions, patient support programs, and clinical trial recruitment, all designed to bridge the gap between pharmaceutical brands and the healthcare providers and patients who benefit from their products. By leveraging technology, OPTIMIZERx aims to streamline the path to treatment, ensuring that patients receive the therapies they need while driving adherence and engagement for better health results.
Snapshot
Operations
Products and/or services of OPTIMIZERx
- Omnichannel Patient Engagement: OPTIMIZERx has evolved from its initial focus on point-of-care messaging to an omnichannel approach. DAAP likely goes beyond EHR and ePrescribing platforms, potentially reaching healthcare providers (HCPs) through various digital touchpoints.
- AI-Driven Patient Identification & Targeting: DAAP utilizes artificial intelligence (AI) to identify and target specific patient populations relevant to pharmaceutical or medical device marketing campaigns. This allows for more precise targeting and potentially improves campaign effectiveness.
- Patient Adherence Solutions: While the specific details might not be provided, DAAP likely offers functionalities to address medication adherence, a core focus area for OPTIMIZERx. This could involve features like patient education, medication reminders, or communication channels.
- Tailored Engagement Modules: DAAP goes beyond basic messaging. It offers the ability to create customized engagement modules relevant to specific healthcare providers (HCPs) and patient needs. These modules could involve educational content, interactive tools, or other elements designed to promote positive health behaviors.
- Patient-First Data & Privacy: OPTIMIZERx emphasizes a "patient-first" approach and utilizing patient data responsibly. DAAP likely incorporates features or functionalities that prioritize patient privacy while leveraging data to achieve better outcomes.
- Strategic Marketing Solutions for Life Sciences: OPTIMIZERx provides a comprehensive solution for life sciences companies (pharmaceutical and medical device companies) by combining patient identification, targeted engagement, and potentially adherence-focused functionalities within their DAAP platform. This helps these companies reach the right patients with the right message at the right time, potentially improving brand awareness, medication adherence, and patient outcomes.
OPTIMIZERx executive team
- Mr. Stephen L. SilvestroPresident & CEO
- Mr. Edward Stelmakh C.M.A., M.B.A.Chief Financial & Strategic Officer
- Mr. Brendan MerrellChief Operating Officer
- Ms. Marion K Odence-FordChief Legal & Administrative Officer
- Ms. Maira AlejandraMedia Relations Manager
- Mr. Andrew Jacob D'SilvaChief Business Officer
- Dr. Doug BeschChief Product Officer & CTO
- Ms. Theresa GrecoChief Commercial Officer
- Ms. Heather FavazzaController
- Ms. Sheryl KearneyHuman Resources Manager